Which of the following statements made by the nurse during patient education is incorrect regarding the goals of antianginal therapy? "Antianginal drug therapy
a. can reduce the risk of myocardial infarction and death."
b. must be used in conjunction with antihypertensive agents."
c. can reduce the intensity of anginal attacks."
d. can prevent myocardial ischemia."
B
Antianginal therapy does not have to be used in conjunction with antihypertensive agents.
Research indicates that antianginal therapy reduces the risk but does not prevent myocardial in-farction and death and is intended to reduce the intensity and frequency of anginal attacks which are caused by myocardial ischemia.
You might also like to view...
A patient has safely given birth to her first child, a healthy baby boy. The obstetrical nurse who provided labor support is aware that the infant possesses natural (innate) immunity that can protect him from many pathogens
Which of the following statements most accurately describes an aspect of natural immunity? A) The primary role of innate immunity is to facilitate the creation of the most common antibodies. B) Innate immunity is dependent on the ability of cells to differentiate between "self" and "non-self" cells. C) Innate immunity results from in utero exposure to antigens. D) Innate immunity is broadly divided into the categories of active and passive immunity.
Which condition should contraindicate use of progestins?
a. Advanced breast cancer b. Menopausal symptoms c. Endometriosis d. Undiagnosed vaginal bleeding
The nurse understands that neurotransmitters have a direct relationship to many mental health disorders and explains to a family member that the client's depression may be related to a deficiency of:
A) serotonin. B) epinephrine. C) acetylcholine. D) histamine.
A malnourished client was started on enteral nutrition 7 days ago. The nurse anticipates that which of the following laboratory measurements will rise if nutritional therapy is effective?
1. serum albumin 2. total protein 3. prealbumin 4. serum glucose